Traders News Source Issues Stocks on Watch and a New Feature Report
January 25 2018 - 7:05AM
InvestorsHub NewsWire
January 25, 2018 -- InvestorsHub
NewsWire -- Traders News Source, a leading independent equity
research and corporate access firm focused on small and mid-cap
public companies is issuing a report with no obligation on
Curis Stock Price (NASDAQ: CRIS),
BIOAMBER INC. (NYSE:
BIOA), ProText Mobility, Inc. (OTC:
TXTM), Akers Biosciences, Inc. (NASDAQ:
AKER) and a comprehensive
feature report in one of the hottest sectors in the market.
Curis (NASDAQ: CRIS) Curis recently announced initiation of Phase 1
trial of their drug CA-4948 for the treatment of patients with
lymphoma. CA-4948 is a first-in-class, orally available to patients
with advanced solid tumors or lymphomas. Curis is a biotechnology
company focused on the development and commercialization of
innovative and effective drug candidates for the treatment of human
cancers.
Get our latest research on a highly-undervalued oil and gas company
READ MORE
Copy and paste to your browser may be required to view the
report – http://bit.ly/2BoBy1P-Feature-Report
BIOAMBER INC. (NYSE: BIOA) uses sugars instead of fossil fuels and
sells competitively priced, sustainable chemicals with strong
profit margins and the cleanest environmental footprint in the
industry. BIOAMBER INC. is also currently developing a second
product platform that uses biotechnology to produce nylon.
ProText Mobility, Inc. (OTC: TXTM) announced that it has signed a
binding letter of intent to acquire up to 100% of the ownership in
Growprocess, Inc., a blockchain and cannabis compliance advisory
firm that has set out to develop a next generation seed-to-sale
Blockchain digital ledger platform for the legal cannabis industry.
Their Phytofare® catechin complex is now providing inhibiting
benefits with metabolic syndrome conditions of obesity, type-2
diabetes and cardiovascular risk.
Get our latest research on a highly-undervalued oil and gas company
READ MORE
Copy and paste to your browser may be required to view the
report – http://bit.ly/2BoBy1P-Feature-Report
Akers Biosciences, Inc. (NASDAQ: AKER) is a major developer in the
health testing and screening products. Tests are designed to
provide the same level of accuracy as traditional laboratory
testing methods, but at a fraction of the cost and turn-around
time. With numerous products now available to physicians this will
speed up the diagnoses and plan of care time for each patient.
FORWARD-LOOKING
DISCLAIMER
This press release may contain
certain forward-looking statements and information, as defined
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, and is subject
to the Safe Harbor created by those sections. This material
contains statements about expected future events and/or financial
results that are forward-looking in nature and subject to risks and
uncertainties. Such forward-looking statements involve risks,
uncertainties and other factors, which may cause the actual
results, performance or achievements of the subject company in this
report to be materially different from the statements made
herein.
COMPLIANCE PROCEDURE
Content is researched, written and
reviewed on a best-effort basis. Information in this release is
fact checked and produced on a best efforts basis. However, we are
only human and are prone to make mistakes. If you notice any errors
or omissions, please notify us below. The subject Company has not
compensated Traders News Source for the creation or dissemination
of this report. Traders News Source is the party responsible for
issuing the press release and for hosting the full analyst report
on Traders News Source website.
NOT FINANCIAL ADVICE
Traders News Source makes no
warranty, expressed or implied, as to the accuracy or completeness
or fitness for a purpose (investment or otherwise), of the
information provided in this document. This information is not to
be construed as personal financial advice. Readers are encouraged
to consult their personal financial advisor before making any
decisions to buy, sell or hold any securities mentioned
herein.
NO WARRANTY OR LIABILITY
ASSUMED
Traders News Source is not
responsible for any error which may be occasioned at the time of
printing of this document or any error, mistake or shortcoming. No
liability is accepted by Traders News Source whatsoever for any
direct, indirect or consequential loss arising from the use of this
document. Traders News Source expressly disclaims any fiduciary
responsibility or liability for any consequences, financial or
otherwise arising from any reliance placed on the information in
this document. Traders News Source does not (1) guarantee the
accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
Source: Traders News
Source
Contact:
editor@tradersnewssource.com
ProText Mobility (PK) (USOTC:TXTM)
Historical Stock Chart
From Nov 2024 to Dec 2024
ProText Mobility (PK) (USOTC:TXTM)
Historical Stock Chart
From Dec 2023 to Dec 2024